Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Trial crawled date : 2021 - 05 - 12 save search
Ascendis Pharma A/S Announces Expansion of Global Clinical Reach for TransCon™ PTH with Filing of the Clinical Trial Notification for Phase 3 Clinical Trial in Adults with Hypoparathyroidism in Japan
Published: 2021-05-12 (Crawled : 21:00) - globenewswire.com
ASND | $143.14 -1.17% -1.18% 230K
|
Health Technology
|
| O: -0.23%
H: 0.75%
C: -6.88%
expansion phase 3 trial
Celyad Oncology to Present Data from Phase 1 IMMUNICY-1 Trial of Non-Gene Edited Allogeneic CAR T Candidate CYAD-211 in Relapsed/Refractory Multiple Myeloma at the European Hematology Association Virtual Congress
Published: 2021-05-12 (Crawled : 20:00) - celyad.com
CYAD | $0.47 -12.49% 49K
|
Health Technology
|
| O: 11.11%
H: 1.69%
C: -2.71%
europe phase 1 trial phase 3 phase 2 car-t
Global Clinical Trials Market Report 2021: Market Players are Undertaking Growth Strategies Such as Mergers and Acquisitions Along with New Product Launches
Published: 2021-05-12 (Crawled : 19:00) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: 0.5%
H: 0.42%
C: -0.03%
GSK | News | $40.86 -0.92% -0.15% 1.7M
|
Health Technology
|
| O: -0.31%
H: 1.28%
C: 1.15%
MEDP | $397.79 -2.3% -2.35% 420K
|
Commercial Services
|
| O: 1.12%
H: 0.91%
C: -1.59%
acquisition clinical trials acquisitions growth new product trial merge
Clinical Trial Manager (CTM)/Sr. CTM
Published: 2021-05-12 (Crawled : 17:00) - nurixtx.com
NRIX 6 d | $13.73 -2.83% -2.91% 520K
|
Health Technology
|
| O: -2.32%
H: 4.49%
C: -1.7%
trial
Global Industrial Weighing Equipment Market to Reach $2.8 Billion by 2027
Published: 2021-05-12 (Crawled : 15:00) - prnewswire.com
MTD | $1235.37 -0.48% 0.0% 120K
|
Health Technology
|
| O: -0.71%
H: 2.14%
C: 0.83%
trial
$ 20.47 Million Growth Expected in Amino Acid Analyzer for Industrial, Preclinical, and Clinical Usage Market | COVID-19 Impact Analysis in Q1 2021| North America to Notice Maximum Growth | Technavio
Published: 2021-05-12 (Crawled : 15:00) - prnewswire.com
TMO | News | $577.39 0.49% 0.0% 2M
|
Health Technology
|
| O: -1.36%
H: 1.38%
C: -0.64%
covid growth trial preclinical pre-clinical
Agios to Present Updated Data from Clinical Trials of Mitapivat in Pyruvate Kinase Deficiency and Thalassemia in Oral Presentations at the European Hematology Association Annual Congress
Published: 2021-05-12 (Crawled : 14:15) - globenewswire.com
AGIO | $31.67 -0.44% -0.44% 540K
|
Health Technology
|
| O: -0.85%
H: 1.27%
C: -2.48%
presentation europe clinical trials trial
CSX Chief Financial Officer to Address Wolfe Research Transportation and Industrials Conference
Published: 2021-05-12 (Crawled : 14:15) - globenewswire.com
CSX | News | $33.65 -3.08% -3.18% 24M
|
Transportation
|
| O: -0.59%
H: 0.55%
C: -1.29%
research trial conference
X4 Pharmaceuticals Announces Positive Preliminary Data from Ongoing Phase 1b Clinical Trial of Mavorixafor in Waldenström’s Macroglobulinemia as Published in EHA Abstract
Published: 2021-05-12 (Crawled : 14:15) - globenewswire.com
ABBV | News | $167.8 -1.03% -0.06% 4.1M
|
Health Technology
|
| O: -0.03%
H: 1.0%
C: 0.1%
XFOR | $1.28 4.06% 3.91% 2.2M
|
Health Technology
|
| O: -1.39%
H: 18.59%
C: 3.08%
ongoing phase 1 positive trial phase 1b phase 2b
GT Biopharma Announces Update On The Commencement Of The GTB-3550 TriKE™ Monotherapy Phase 2 Clinical Trial And Solid Tumor TriKE™ Product Candidates
Published: 2021-05-12 (Crawled : 13:00) - biospace.com/
GTBP | $3.65 -2.44% 370
|
Manufacturing
|
| O: -0.4%
H: 1.93%
C: -14.03%
phase 2 biopharma therapy trial solid tumors
Leap Therapeutics and Flagship Biosciences Develop Image Analysis RNAscope Assay for Prospective Trial Enrollment
Published: 2021-05-12 (Crawled : 13:00) - biospace.com/
LPTX | $3.285 2.66% 2.59% 190K
|
Health Technology
|
| O: 1.92%
H: 6.92%
C: 0.0%
BGNE | $144.0 3.61% 3.48% 220K
|
Health Technology
|
| O: -1.88%
H: 1.82%
C: -1.04%
trial imaging enroll
Checkpoint Therapeutics Announces Completion of Enrollment in the Registration-Enabling Trial of Cosibelimab in Metastatic Cutaneous Squamous Cell Carcinoma
Published: 2021-05-12 (Crawled : 12:15) - globenewswire.com
FBIO | $1.785 -1.38% -1.4% 120K
|
Health Technology
|
| O: -0.79%
H: 2.93%
C: -1.87%
CKPT | $1.44 0.35% 0.35% 180K
|
Health Technology
|
| O: -2.0%
H: 5.23%
C: -2.04%
trial enroll cell carcinoma cosibelimab
Infinera Completes Successful Trial of XR Optics with NBN Co
Published: 2021-05-12 (Crawled : 12:15) - globenewswire.com
INFN | $4.98 1.84% 1.81% 1.7M
|
Electronic Technology
|
| O: -1.58%
H: 1.02%
C: -2.34%
trial
Ocuphire Completes Enrollment in VEGA-1 Phase 2 Clinical Trial Investigating Nyxol® in Combination with Low-Dose Pilocarpine for Treatment of Presbyopia
Published: 2021-05-12 (Crawled : 12:15) - biospace.com/
OCUP | News | $1.52 -1.3% -1.32% 90K
|
Health Technology
|
| O: -1.85%
H: 3.29%
C: 2.12%
treatment phase 2 trial enroll presbyopia
The path to zero-waste across South America: the latest Top Story available on CNHIndustrial.com
Published: 2021-05-12 (Crawled : 11:00) - globenewswire.com
CNHI | $11.4 -1.55% -1.32% 15M
|
Producer Manufacturing
|
| O: 0.49%
H: 0.85%
C: -3.02%
test trial
Gainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Your saved searches
Save your searches and get alerts when important news are released.